ArticleBMC cancer2024

The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.

Leen Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.